Clinical trial
Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer
NCT00616122
Study timeline
Study start (actual)2006-03-01Date precision: day
Registry last updated2020-01-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
methotrexateDRUG · verified · RxNorm: methotrexate
sunitinib malateDRUG · verified · RxNorm: sunitinib malate
Sponsors & collaborators
University of California, San Franciscolead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00616122 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.